Our
added valuePX’Therapeutics particularly differentiate from other CMOs by its integrated way of working from early stage research and protein engineering to phases I & II clinical production. For your information, we have been extensively involved into the discovery, development and manufacturing of drug targets and therapeutic proteins during the past 8 years with over 500 projects performed. We have thus gained substantial experience in the production of challenging proteins and developed trusted relationships with now more than 120 pharmaceutical, biotech and academic partners (European & American).
Our vocation is to become a value-added partner to most of biopharmaceutical companies and to play a leading role in the generation of valuable target and therapeutic proteins. We commit ourselves to increase the research productivity of our clients by reducing development times and increasing their protein pipelines. We also aim at remaining at the cutting edge of protein science by establishing and maintaining strong relationships with academic research centres.